Current Fellows & Alumni

Se Ryeong (Rhea) Jang, MPH (2019-2021)
Associate Director, Real World Value & Evidence, Solid Tumor 
Johnson & Johnson Innovative Medicine 

Sonia Lee, MSPH (2017-2019)
Senior Analyst, Health Economics                                                   
Vertex Pharmaceuticals 

Po-Han (Brian) Chen, ScM (2015-2017)
Director, Global Health Economics, Value & Outcomes Research
Teva Pharmaceuticals 

Carine Chia-Wen Hsiao, BScPharm, MHS (2013-2015)
Global Director, Health Economics & Outcomes Research
Alcon

Sally Liu, MS, MPH (2012-2013)
Head of Access Strategy, HEOR & Pricing 
Amgen, China 

Sangtaeck Lim, MA, MPH (2010-2012)
Associate Director, Health Economics & Outcomes Research
Teva

Anita Mohandas, MSc (2009-2011)
Director, Health Economics & Outcomes Research 
Twill

Madhusree Singh, MD, MRCP (2005-2007)
Primary Care Physician
U.S. Department of Veteran Affairs
Associate Professor
University of California, San Diego 

Nikita Mody Patel, PharmD, MBA (2004-2006)
Executive Director, Value, Access & Policy 
Appellis Pharmaceuticals 

Christopher Salvador, PharmD (2003-2005)
Associate Director, Market Research, Oncology
Pharmacylics, AbbVie Company

Mirko V. Sikirica, PharmD (2002-2004)
Compound Market Access Lead, Immunology
Janssen

Purna K. Dhru, PharmD (2001-2003)
Senior Manager, Clinical Outcomes
Medco Health Solutions

Craig Roberts, PharmD, MBA, MPA (2000-2002)
VP, Vaccines 
Center for Observational and Real-World Evidence
Merck

Dennis M. Meletiche, PharmD (1999-2001)
Chief Strategy Advisor
Maple Health Group, LLC

Dilesh P. Doshi, PharmD (1998-2000)
VP, Global Health Economics & Outcomes Research 
Acadia Pharmaceuticals Inc.

Michael Schaffer, PharmD, MBS (1997-1999)
Director, Pharmacy Products
Sanovia Corporation

Phong Duong, PharmD (1995-1997)
Executive Director, Global Market Access & Policy
Merck

Omar Shoheiber, PharmD, MBA (1994-1996)
CEO
Juno Wellness 

Alexander Litvintchouk, PharmD  (2022-2024)
Global Market Access Manager 
Johnson & Johnson Innovative Medicine 

Matthew Molaei, PharmD, MS (2020-2022)
HEOR Scientist
Eil Lilly & Company

Dexter Waters, MSPH, MS (2019-2021)
Associate Director, Real World Value & Evidence, Oncology
Janssen, Johnson & Johnson

Jennifer Voelker, PharmD (2017-2019) 
Product Director, US Bladder Cancer HCP Marketing 
Johnson & Johnson Innovative Medicine

David Singer, PharmD (2016-2018)
Director, U.S. Health Outcomes & Epidemiology 
GSK 

Jacquelyn McRae, PharmD, MS (2015-2017)
Vice President, Policy and External Affairs 
National Pharmaceutical Council 

Matthew Alcusky, PharmD, MS (2014-2016)
Assistant Professor, Department of Population Health & Quantitative Health Sciences
University of Massachusetts Medical School

Tony Amos, PharmD, MS (2013-2015)
Director, RWE & Integrated Evidence Strategy (Lung Cancer Initiative)
Johnson & Johnson

Jessica (Lopatto) Kenley, PharmD (2012-2014)
Market Access Manager, Cardiac Rhythm & Heart Failure
Medtronic

Zoe Clancy, PharmD, MS (2011-2013)
Consultant

Kellie Morland, PharmD, MS (2010-2012)
Executive Health Economics & Outcomes Research Liaison 
United Therapeutics Corporation 

S. Lane Slabaugh, PharmD, MPH (2009-2011)
Associate Director, Cell Therapy Market Access
Bristol Myers Squibb

Safiya Abouzaid, PharmD, MPH (2008-2010)
Health of  U.S. Strategic Contracting
Jannsen, Johnson & Johnson 

Paresh Chaudhari, PharmD, MPH (2007-2009)
President & Head of Health Economics & Outcomes Research 
Rx Tech Solutions, LLC. 

Seina P. Lee, PharmD, MS (2006-2008)
Director, Global Commercial Strategy, Dermatology Lead
Janssen, Johnson & Johnson 

Joshua Gagne, PharmD, MSPH, ScD (2005-2007)
Vice President & Global Health of Epidemiology 
Johnson & Johnson

Sara Poston, PharmD (2004-2006)
Director, Health Outcomes Insights, Vaccines
GlaxoSmithKline

Vanja Sikirica, PharmD, MPH (2003-2005)
Senior Director Epidemiology Lead Therapeutics (Rare Disease, Autoimmune & Emerging) & Oncology  
Moderna

Jamie B. Forlenza, PharmD, MS (2002-2004)
Director, Innovative Methods & Design at Johnson & Johnson Clinical Operations
Johnson & Johnson 

Chureen Carter, PharmD, MS (2001-2003)
VP, Global Data, Platforms & Partnerships
Janssen, Johnson & Johnson 

Tammy Curtice, PharmD, MS, MBA (2000-2002)
HEOR Value Engagement Lead
AbbVie

Mark J. Bachleda, PharmD, MBA (1999-2001)
Chief Commercial Officer 
Galera Therapeutics, Inc. 

Julie Locklear, PharmD, MBA (1998-2000)
Consultant

Thomas Yuran, PharmD (1997-1999)
Medical Affairs Executive Director 
Genentech

Matthew Nguyen, PharmD, MBA (1996-1998)
VP 
MannKind Corporation 

Dominique Comer Medaglio, PhD, PharmD, MS (2011-2014)
Manager, Epidemiology and Real-World Data Sciences
Johnson & Johnson MedTech

Joseph Couto, PharmD, MBA (2008-2010)
Executive Director, Specialty Program Evalution & Outcomes, CVS Specialty
CVS Health 

Dea Belazi, PharmD, MPH (2001-2003)
President & CEO
AscellaHealth, LLC.

Amy L. Phillips, PharmD (2000-2002)
Associate Director, Regional Outcomes & Market Research
EMD Serono Inc.

Susan S. Kim, PharmD (1999-2001)
Executive Director, US Marketing, Immunology & Inflammation
Bristol Myers Squibb

Charlene Tugwete, PharmD, MS  (2023-2025)
US HEOR Immunology
Novartis

Jennifer Nguyen, PharmD (2021-2023)
Senior Manager, HEOR Oncology 
Novartis

Shivangi Patel, PharmD (2020-2022)
Senior Manager, Patient Centered Outcomes Research 
Global Market Access 
Sharepta Therapeutics 

Laetitia N'Dri, PharmD, RPh MS (2019-2021)
Associate Director
Value & Implementation, Outcomes Research
Merck

Karishma Shelley, PharmD, MS (2018-2020)
Associate Director
Health Economics & Outcomes Research (HEOR)
Bristol Myers Squibb

Stefan Varga, PharmD (2015-2017)
Director, WW HEOR 
Bristol Myers Squibb 

Ashok Vegesna, PharmD (2014-2016)
Director, National Accounts, Novartis Gene Therapies
Novartis

Tom Karagiannis, PharmD, MS (2013-2015)
Head, Immunology Market Access & HEOR (Canada)
AbbVie

Slaven Sikirica, MSc (2012-2014)
Senior Director
Lexicon Pharmaceuticals

Daniel Huang, PharmD, MPH (2023-2025) 
Manager, Global Real World Evidence 
Johnson and Johnson Innovative Medicine

Vijay Nadipelli, BPharm, MS (1995-1997)
Senior Director, Global Value & Access 
Acceleron Pharma 

Joseph Doyle, RPh, MBA (1996-1998)
Pharmacy Manager
Dr. Gs Pharmacy by the Sea 

John Fastenau, PhD, RPh, MPH (1995-1997)
Senior Director, Patient Reported Outcomes
Janssen, Johnson & Johnson

Feride H. Frech-Tamas, PhD, RPh, MPH (1994-1996)
Senior Director, HEOR & RWE 
Eisai 

Chelsey Ali, PharmD (2023-2025)

Carolyn Saba-Abaniel, PharmD (2022-2024)
Associate Director, Market Access
Prime-Aventine Consulting

Amy Yang, PharmD (2021-2023)
Senior Manager, Global HEOR  
Teva

Anna Chen, PharmD (2020-2022)
Associate Director, Health Economics & Outcomes Research/Real World Evidence 
Sandoz 

Seojin Park, PharmD (2019-2021)
Associate Director, US Medical Affairs, Patient Access and Quality
Gilead Sciences

Phoung Pham, PharmD, MBA (2022-2024)